Sexual side effects
- Medical Review: Anne Katz RN, PhD
It’s normal to lose interest in sex at times after diagnosis and during treatment. Breast cancer treatments or the cancer itself can cause fatigue, discomfort, pain, and other side effects that impact your sexual desire and activity. These side effects can happen during treatment, or months or years afterward.
It's important to know that you are not alone. LBBC is here for you with support and guidance to help you manage side effects and stay connected to your sexual self.
Below, we'll talk about common breast cancer treatment side effects that can impact your sexual life. We'll also provide links to detailed information on maintaining your sexual health, getting comfortable with your body image, communicating with a partner, and more.
Sexual side effects of different treatments
Many breast cancer treatments can cause side effects that can interfere with sexual life. But not everyone experiences every side effect, and there are many ways to manage them if they happen. In this section, we’ll talk about the common treatments that can cause these side effects.
Surgery
Different breast cancer surgeries can result in sexual side effects:
- Mastectomy and lumpectomy are cancer-removing surgeries that remove all or part of the breast.
- Breast reconstruction rebuilds the breast after cancerous tissue is removed.
- Lymph node surgery (sentinel node biopsy or axillary node dissection) removes tiny immune system organs called lymph nodes so that doctors can check for cancer spread.
- Ovary removal is recommended for some women, especially if they have an inherited BRCA mutation that greatly increases the risk of breast and ovarian cancers.
The physical effects of these surgeries can change your body image, or the way you feel about your body. They can also change how your body feels to you and your partner. And sometimes, these changes can bring a loss of interest in sex. Here are some of the surgery side effects that can impact sexuality:
- Pain: As you recover from breast surgery, there can be burning and constricting sensations or sudden, sharp pain as your body heals. For some people, there can be chronic, ongoing post-surgery pain.
- Loss or change of sensation in the breast: Breast surgery cuts nerves and can change or eliminate feeling sensation in and around the breast, and on the breast skin. Some mastectomy surgeries require removal of the nipple. All of these may concern you if you enjoy breast play or have orgasms when your breasts, nipples, or areolae (the area around the nipple) are touched.
- Lymphedema: Some people who've had underarm lymph nodes removed later develop temporary or permanent swelling in the arm. Lymphedema can also happen in other parts of the body where surgery took place, such as the breast or abdomen. This can be painful, and it can affect the way you feel about your body.
- Axillary web syndrome, also known as cording: This is another potential side effect of underarm lymph node removal. The term "cording" comes from the rope-like structures under the skin of the inner arm that develop near the site of scarring and may extend down the inner arm to inside the elbow. The cords tend to be painful and tight, making it difficult to lift your arm higher than the shoulder or fully extend the elbow.
- Menopausal symptoms: For women who choose to have their ovaries surgically removed before natural menopause, the immediate result is medical menopause, which quickly brings on hot flashes, night sweats, vaginal and vulvar dryness, mood changes, fatigue, and changes in sex drive.
Radiation therapy
Radiation therapy directs high-energy x-rays at specific areas to kill cancer cells. Breast radiation does not directly decrease sexual arousal or response, but it can cause side effects that may impact your sexual life, including:
- Breast discomfort, due to tenderness and swelling
- Fatigue
- Range of motion problems in areas around the breast because of scarring or lymphedema
- Skin changes, such as redness, changes in sensitivity, and thickening of the breast tissue or skin
If you enjoy breast play or have orgasms from touching your breasts, nipples, or areolae, skin changes may be of special concern.
Chemotherapy
Chemotherapy travels through the bloodstream to kill cancer cells that are growing or dividing quickly. Although very effective at killing cancer cells, chemotherapy also affects all quickly dividing cells — even healthy ones. These include the cells of the ovaries, which produce estrogen. Estrogen helps to maintain the vaginal moisture that makes sex comfortable.
Sometimes chemotherapy irritates the tissues of the vulva (the area outside the vagina) and the vagina itself, making it dry and inflamed. Irritation can spark flare-ups of genital herpes or genital warts if you had them in the past. Other side effects from chemotherapy may include:
- Low libido or sexual desire
- Difficulty getting aroused or reaching orgasm
- Lack of energy for sexual activity because of nausea, vomiting, or fatigue
- Pain during penetration when the penis, a sex toy, or a finger is inserted into the vagina
- Pain when the vulva is touched
- Menopausal symptoms, such as hot flashes and irregular or no menstrual periods
- Light spotting after penetration due to thinning of the vaginal lining
Targeted therapy
Targeted therapies are medicines that target changes in specific proteins or markers on or within cancer cells that help the cells to grow. Instead of killing all fast-growing cells, these medicines target just the cancer cells.
These medicines often have fewer side effects than chemotherapy, but they are usually given with chemotherapy. If you receive both treatments, you could have the same common side effects as you would with chemotherapy alone, such as hair loss, nausea, fatigue, vaginal dryness, and loss of sexual desire.
Hormonal therapy
Hormonal therapy blocks or lowers the hormones that hormone receptor-positive breast cancer needs to grow. Hormonal therapy includes treatments such as:
- Tamoxifen, approved for pre- and postmenopausal women
- Aromatase inhibitors, approved for postmenopausal women
Hormonal therapy can increase menopausal symptoms and impact your sexual health. Side effects include:
- Hot flashes
- Night sweats
- Insomnia
- Irritability
- Joint pain
- Reduced sex drive
- Vaginal and vulvar dryness
- Vaginal atrophy (thinning of the vaginal walls)
- Pain during sex
- Irregular periods if you are premenopausal
- Bone loss
Oophorectomy and ovarian suppression medicines
If you test positive for an inherited BRCA1 or BRCA2 mutation, the risk of developing breast cancer and ovarian cancer is significantly higher than for women who do not carry these mutations. One risk-reducing strategy is surgery to remove the ovaries, a procedure called oophorectomy. If you are premenopausal, ovary removal will put you in immediate menopause.
For some pre- or perimenopausal women, ovarian suppression may be recommended. Ovarian suppression uses medicines such as leuprolide (Lupron) and goserelin (Zoladex) to stop the ovaries from making estrogen. These medicines cause symptoms that last as long as you're receiving the medicine, and for a short time afterward.
Both oophorectomy and ovarian suppression can result in menopausal symptoms such as hot flashes, vaginal and vulvar dryness, lowered sex drive, and painful sex. Especially with oophorectomy, symptoms can be more intense than they would be if you went through natural menopause.
Antidepressants
Some antidepressants, called selective serotonin reuptake inhibitors (SSRIs), can lessen sexual desire and affect your ability to reach orgasm. SSRIs are sometimes prescribed to help with hot flashes.
Depression is common during and after treatment for breast cancer, and depression can lead to a loss of interest in sex. If antidepressants are part of your treatment and you believe they are adding to your sexual concerns, talk with your doctor about possibly switching to another antidepressant or stopping altogether.
Anti-nausea medicines
Antiemetics, medicines used to control or stop nausea during chemotherapy or other treatments, have side effects that may interfere with sexual desire. These include drowsiness, diarrhea, constipation, headache, and fatigue.
Your sex life is not over
We know that the above list of side effects can feel overwhelming to read. It's important to know that not everyone will experience all the side effects mentioned above. And no matter what kind of treatment you have, breast cancer does not mean an end to your sex life. There is lots of help available that can restore sexual enjoyment and intimacy.
If you feel like you do want to try sexual activity, start slowly. See what different kinds of nonsexual touch feel like to you. If you have a partner, touch such as holding hands, stroking an arm, or hugging can nurture intimacy and help you feel connected. Whether you are partnered or single, there are ways to take care of yourself and maintain a sexual life.
If sex feels painful, there are many things you can do, including stretching pelvic muscles with dilators, using vaginal lubricants and moisturizers, and trying new positions. Learn more about managing pain during sex.
Finding help for sexual side effects
As you plan treatment, talk with your care team about potential sexual side effects and any steps you can take to manage them. Many healthcare professionals are sensitive to this issue and want to help you. Even if they don’t have all the answers, your care team can direct you to other professionals who can help.
We know that it can sometimes feel uncomfortable to bring up sexual side effects with your oncologist or oncology nurse. But don't be afraid to ask for advice or for a referral to a sexual health specialist. Here are some tips to start the conversation:
- When you make your next oncologist appointment, mention that you would like a few extra minutes to ask questions.
- Before your appointment, write down the symptoms you've been having, as well as any questions you have.
- Be as specific as you can. For example, say, “I have pain during sexual penetration. What can I do to get relief?”
- Rehearse what you want to say before your appointment. It can help to say the words out loud to a partner or friend, or in front of a mirror.
If your care team is unsure how to help, or if they seem uncomfortable discussing your sexual concerns, ask for a referral to a specialist in sexual health, cancer survivorship medicine, or both. These professionals give specialized care to people who are living with the sexual side effects of cancer treatment.
To learn more about how to manage sexual side effects, visit our section on sex and intimacy.
Sexual side effects and metastatic breast cancer treatment
Metastatic breast cancer (MBC) treatment can cause sexual side effects the same way that early-stage breast cancer treatment can. Side effects can vary based on the type of treatment you have. If you’re having difficulty with sexual side effects, you are not alone. Talk with your nurse or doctor about what you’re experiencing. There are many ways to address sexual side effects, and your care team can make recommendations.
If the cancer is hormone receptor-positive, treatment may start with hormonal therapy, with or without targeted therapy. These medications work to lower or block estrogen. Other treatments that may be recommended for MBC can also impact estrogen and the ovaries. These include oophorectomy, ovarian suppressing medicines, and chemotherapy. All of these treatments can cause sexual side effects.
Hormonal therapy
Hormonal therapies used to treat MBC include:
- Aromatase inhibitors, approved for postmenopausal women
- Fulvestrant (Faslodex), approved for postmenopausal women
- Elacestrant (Orserdu), approved for postmenopausal women
- Tamoxifen, approved for pre- and postmenopausal women
- Toremifene citrate (Fareston), approved for postmenopausal women
Oophorectomy and ovarian suppression medicines
If you have tested positive for a BRCA gene mutation that raises your risk of ovarian cancer, ovary removal (oophorectomy) may be recommended for you. If you are premenopausal, this surgery causes immediate menopause (medical menopause) and sexual side effects.
If you are premenopausal and your care team has recommended taking ovarian suppressing medicines to further lower estrogen in your body, you will likely experience menopausal side effects that can interfere with sexual life.
Chemotherapy
Chemotherapy is another treatment that impacts the ovaries and causes sexual side effects. Chemotherapy can sometimes irritate the tissues outside the vagina (the vulva) and the vagina itself.
Still, in MBC treatment, chemo is often given in single doses, not combinations. If you're being treated with one chemotherapy medicine and not taking any other medicines that impact estrogen, sexual side effects may not be as intense as they might be if you were being treated with a chemo combo.
Specific side effects that can impact sexual life
The treatments mentioned above can cause these sexual side effects:
- Hot flashes
- Night sweats
- Insomnia
- Irritability
- Joint and bone pain
- Loss of libido
- Vaginal and vulvar dryness
- Vaginal atrophy (thinning of the vaginal walls)
- Pain during sex
- Irregular periods if you are premenopausal
- Bone loss
Not everyone experiences every side effect. But if you're being treated for MBC, just being on multiple treatments and experiencing many different emotions can have a big impact on sexuality. An MBC diagnosis can be exhausting, and if you have bone metastasis or bone loss, it can make some sexual positions uncomfortable. Hot flashes and night sweats don't feel sexy, and if you have pain during sex, or if penetration is not possible, it can be upsetting. It's not always easy to find the energy or desire to be sexual. And that's okay. Whether or not you engage in sex is 100% up to you. And if you do decide you want to be sexual, there are many, many options to ease side effects and support enjoyable sex.
It's important to communicate with your care team about sexual side effects so that they can provide guidance and recommend treatments that can help. You can also ask for a referral to see a healthcare professional or counselor who specializes in sexual health and cancer treatment.
To learn more about how to manage sexual side effects, visit our page on navigating intimacy and sexuality with MBC, as well as our sex and intimacy section.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator
- selective serotonin reuptake inhibitor
- sentinel lymph node
- sentinel lymph node biopsy
- sentinel lymph node mapping
- sepsis
- sequential AC/Taxol-Trastuzumab regimen
- sequential treatment
- SERM
- sertraline
- Serzone
- sestamibi breast imaging
- sexuality
- sibling
- side effect
- silicone
- simple mastectomy
- simulation
- Single-agent therapy
- sleep disorder
- social service
- social support
- social worker
- sodium thiosulfate
- soft tissue
- solid tumor
- somatic
- somatic mutation
- sorafenib
- specialist
- specificity
- spiculated mass
- spinal anesthesia
- spinal block
- spiral CT scan
- spirituality
- sporadic cancer
- SSRI
- stable disease
- stage
- stage 0 breast carcinoma in situ
- stage 0 disease
- stage I breast cancer
- stage IA breast cancer
- stage IB breast cancer
- stage II breast cancer
- stage II breast cancer
- stage IIA breast cancer
- stage IIB breast cancer
- stage III breast cancer
- stage III lymphedema
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- staging
- stamina
- standard of care
- standard therapy
- statistically significant
- stent
- stereotactic biopsy
- stereotactic radiosurgery
- sterile
- sternum
- steroid
- stress
- strontium
- study agent
- subcutaneous
- subcutaneous port
- subjective improvement
- subset analysis
- supplemental nutrition
- supplementation
- support group
- supportive care
- supraclavicular lymph node
- surgeon
- surgery
- surgical biopsy
- surgical menopause
- surgical oncologist
- survival rate
- symptom
- symptom management
- symptomatic
- synergistic
- synthetic
- syringe
- systemic
- systemic chemotherapy
- systemic disease
- systemic therapy
- TAC regimen
- tai chi
- tailored intervention
- talk therapy
- tamoxifen
- targeted therapy
- taxane
- Taxol
- Taxotere
- Tc 99m sulfur colloid
- technician
- terminal disease
- therapeutic
- therapeutic touch
- therapy
- thermography
- thiethylperazine
- thiotepa
- third-line therapy
- thrush
- time to progression
- tinnitus
- tissue
- tissue flap reconstruction
- TNM staging system
- tomography
- tomotherapy
- topical
- topical chemotherapy
- topoisomerase inhibitor
- total estrogen blockade
- total mastectomy
- total nodal irradiation
- total parenteral nutrition
- toxic
- toxicity
- tracer
- traditional acupuncture
- tranquilizer
- transdermal
- transfusion
- transitional care
- translational research
- trastuzumab
- trauma
- treatment field
- trigger
- trigger point acupuncture
- triple-negative breast cancer
- tumescent mastectomy
- tumor
- tumor antigen vaccine
- tumor board review
- tumor burden
- tumor debulking
- tumor load
- tumor marker
- tumor volume
- Tykerb
- ulcer
- ulceration
- ultrasound-guided biopsy
- ultrasound/ultrasonography
- ultraviolet radiation therapy
- uncontrolled study
- undifferentiated
- unilateral
- unilateral salpingo-oophorectomy
- unresectable
- unresected
- upstaging
- urticaria
- VACB
- vaccine therapy
- vacuum-assisted biopsy or vacuum-assisted core biopsy
- Valium
- vancomycin
- vandetanib
- vascular endothelial growth factor-antisense oligonucleotide
- vascular endothelial growth factor receptor tyrosine kinase inhibitor
- vein
- Velban
- venipuncture
- venous sampling
- Versed
- vertebroplasty
- vinorelbine
- vital
- vomit
- watchful waiting
- wedge resection
- Wellcovorin
- Western medicine
- WGA study
- white blood cell
- whole cell vaccine
- whole genome association study
- wide local excision
- wire localization
- wound
- X-ray therapy
- Xanax
- Xeloda
- xerostomia